Totoy, Lowell N.
HRN: 07-65-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CO-AMOXICLAV 625MG (TAB)
01/26/2023
02/02/2023
PO
625mg
Q8H
Hacking Injury, Mid Epigastric Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes